News Conference News TCT 2021 EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI Michael O'Riordan October 15, 2021
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Daily News Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6 Michael O'Riordan September 16, 2016